← All peptidesPDA-V1 attestation Citations
verifiedBioGate · GREENGrade B
Melanotan II
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2Non-selective melanocortin receptor agonist (MC1R/MC3R/MC4R); stimulates eumelanin synthesis. Not approved; used off-label with documented adverse events.
cyclic lactamacetylated N-terminusamidated C-terminusNle¹
MW
1024.18
Length
43aa
Posterior
50.9%
Structural preview · ESMFold-2 mockdeterministic per sequence
Backbone preview · cyclic lactam
Cryptographic chain of custody.
- Outer PDA hash
- Inputs hash
- Merkle root
- TEE attestation
- Protocol version
- PDA-V1
- Source
- peptide-md
- Model version
- structure-fm-2026.04
- Candidates emitted
- 5
- Signed
- 2026-04-21T08:14:33Z
Verifiable in your browser at /verifier with
@peptide-md/verifier.Real-world evidence
Cohort-attested outcomes.
Cohorts
1
Participants
195
Mean Δ
+4.69
Δ HRV ms (8-week) · 95% CI [3.17, 6.2]
IPNFT · Molecule IPNFT V2Solana
Melanotan II
6d896e…e96889Royalty cascade
4.61%
Holders
358
Royalty cascade routes lab fees, licensing, and OEA-attested cohort revenues back to holders, the cohort treasury, and the originating researchers in a 60 / 25 / 15 split.
Source literature.
Grade C1998 · J Urol
Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction
Wessells H et al.